APA (7th ed.) Citation

Bart, S., Cannon, K., Herrington, D., Mills, R., Forleo-Neto, E., Lindert, K., & Abdul Mateen, A. (2016). Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. Human vaccines & immunotherapeutics, 12(9), 2278-2288. https://doi.org/10.1080/21645515.2016.1182270

Chicago Style (17th ed.) Citation

Bart, Stephan, Kevin Cannon, Darrell Herrington, Richard Mills, Eduardo Forleo-Neto, Kelly Lindert, and Ahmed Abdul Mateen. "Immunogenicity and Safety of a Cell Culture-based Quadrivalent Influenza Vaccine in Adults: A Phase III, Double-blind, Multicenter, Randomized, Non-inferiority Study." Human Vaccines & Immunotherapeutics 12, no. 9 (2016): 2278-2288. https://doi.org/10.1080/21645515.2016.1182270.

MLA (9th ed.) Citation

Bart, Stephan, et al. "Immunogenicity and Safety of a Cell Culture-based Quadrivalent Influenza Vaccine in Adults: A Phase III, Double-blind, Multicenter, Randomized, Non-inferiority Study." Human Vaccines & Immunotherapeutics, vol. 12, no. 9, 2016, pp. 2278-2288, https://doi.org/10.1080/21645515.2016.1182270.